patients with primary APS, 54 patients with positive aPL serology not meeting clinical criteria for APS and 326 healthy controls adjusted by the month of vitamin D analysis. We considered 30 ng/ml and 10 ng/ml as the thresholds for vitamin D insufficiency and deficiency, respectively. Results: Median levels of vitamin D were similar in the three groups: 21 (range 5-69) in primary APS, 25 (4-50) in the aPL-positive group, and 21 (4-105) in controls. Overall, 53.9% of measurements were performed during the sunny season (April to September). Ten percent of patients with primary APS were males, versus 16% in the aPL serology group and 26% among healthy controls (p=0.007). Mean age was 46±15 in primary APS, 49±17 in the aPL-positive group and 53±10 in the control group (p<0.001). Regarding vitamin D insufficiency, 82% of APS patients had levels of vitamin D (<30 ng/ml) versus 70% and 72% of patients with aPL serology and controls, respectively (p=0.168). When analyzing the prevalence of vitamin D deficiency (<10 ng/ml), we found significant differences across the groups: 16.2% in patients with primary APS, 11.1% in patients with positive serology and only 4.9% in healthy controls (p=0.002). There was no significant association between insufficient levels of vitamin D and the presence of thrombotic or obstetric events. Nevertheless, we found a trend for the presence of more thrombotic events in patients with vitamin D deficiency (p=0.097). Regarding the immunological profile, we found no association between vitamin D and either the number of positive antibodies or their serological evolution. However, we found an association between insufficient levels of vitamin D and the presence of lupus anticoagulant (54.7% vs 18.2%, p=0. Background: Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (aPL) and thrombosis and/or pregnancy morbidity. Although thrombotic and obstetric APS are considered the same disorder, there are pathogenetic and clinical differences between them. Objectives: To describe the epidemiological, clinical and immunological characteristics of a cohort of APS patients from a defined population and to study the differences between thrombotic, obstetric and mixed APS. Methods: Retrospective study including patients attending the rheumatology and the obstetric clinics of a tertiary facility in Northern Spain. All patients met APS classification criteria. Results: We included 84 patients with thrombotic APS, 76 with obstetric APS and 10 with mixed APS. Main demographical characteristics are showed in table. There were differences in the age of discovery a positive serology (46±15 yr in thrombotic APS, 36±8 yr in obstetric, and 36±14 in mixed APS). Moreover, the prevalence of systemic lupus erythematosus (SLE) was higher in patients with thrombotic and mixed APS (26% and 30% vs 5% in obstetric APS, p=0.001). Anticardiolipin antibodies were, overall, the most frequently positive. Lupus anticoagulant was significantly more common in patients with thrombotic and mixed APS (70% and 71% vs 30% in obstetric APS, p=0.002). We found no differences in the load
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patients with primary APS, 54 patients with positive aPL serology not meeting clinical criteria for APS and 326 healthy controls adjusted by the month of vitamin D analysis. We considered 30 ng/ml and 10 ng/ml as the thresholds for vitamin D insufficiency and deficiency, respectively. Results: Median levels of vitamin D were similar in the three groups: 21 (range 5-69) in primary APS, in the aPL-positive group, and 21 (4-105) in controls. Overall, 53.9% of measurements were performed during the sunny season (April to September). Ten percent of patients with primary APS were males, versus 16% in the aPL serology group and 26% among healthy controls (p=0.007). Mean age was 46±15 in primary APS, 49±17 in the aPL-positive group and 53±10 in the control group (p<0.001). Regarding vitamin D insufficiency, 82% of APS patients had levels of vitamin D (<30 ng/ml) versus 70% and 72% of patients with aPL serology and controls, respectively (p=0.168). When analyzing the prevalence of vitamin D deficiency (<10 ng/ml), we found significant differences across the groups: 16.2% in patients with primary APS, 11.1% in patients with positive serology and only 4.9% in healthy controls (p=0.002). There was no significant association between insufficient levels of vitamin D and the presence of thrombotic or obstetric events. Nevertheless, we found a trend for the presence of more thrombotic events in patients with vitamin D deficiency (p=0.097). Regarding the immunological profile, we found no association between vitamin D and either the number of positive antibodies or their serological evolution. However, we found an association between insufficient levels of vitamin D and the presence of lupus anticoagulant (54.7% vs 18.2%, p=0. Background: Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of antiphospholipid antibodies (aPL) and thrombosis and/or pregnancy morbidity. Although thrombotic and obstetric APS are considered the same disorder, there are pathogenetic and clinical differences between them. Objectives: To describe the epidemiological, clinical and immunological characteristics of a cohort of APS patients from a defined population and to study the differences between thrombotic, obstetric and mixed APS. Methods: Retrospective study including patients attending the rheumatology and the obstetric clinics of a tertiary facility in Northern Spain. All patients met APS classification criteria. Results: We included 84 patients with thrombotic APS, 76 with obstetric APS and 10 with mixed APS. Main demographical characteristics are showed in table. There were differences in the age of discovery a positive serology (46±15 yr in thrombotic APS, 36±8 yr in obstetric, and 36±14 in mixed APS). Moreover, the prevalence of systemic lupus erythematosus (SLE) was higher in patients with thrombotic and mixed APS (26% and 30% vs 5% in obstetric APS, p=0.001). Anticardiolipin antibodies were, overall, the most frequently positive. Lupus anticoagulant was significantly more common in patients with thrombotic and mixed APS (70% and 71% vs 30% in obstetric APS, p=0.002). We found no differences in the load Background: Primary Sjögren's syndrome (pSS) is the second most common systemic autoimmune disease, with a female-male ratio of 9:1, and characterized by sicca symptoms of the eyes and mouth, including joint pains and multi-system involvement. pSS affects patients' health-related quality of life (QoL), mental status and relationships with family. In pSS patients, symptoms such as fatigue, depression, arthralgia, fibromyalgia and general loss of well-being are commonly reported. Among them, fatigue is the most common problem that includes physical and mental fatigue, it can be as disabling as pain, which is difficult to manage and has a notable impact on QoL. Fatigue is a tiredness which may be mental, physical, or both, and that results in an inability to function at normal performance levels. However, the underlying pathophysiological mechanisms of fatigue remain unclear. A number of studies have reported the association of fatigue with Primary Sjögren's syndrome (pSS), whereas, because of the small sample size of pSS patients, we still lack large sample studies to find the relationship between pSS and fatigue. Objectives: To investigate the relationship of fatigue severity to other clinical features in primary Sjögren's syndrome (pSS) and to identify factors contributing to the physical and mental aspects of fatigue in Chinese patients. Methods: Sixty-seven consecutive patients with PSS according to the AmericanEuropean Consensus group (AEGG) criteria were included. Demographic, clinical and biological characteristics for all patients were collected. The Fatigue Severity Scale (FSS), Profile of Fatigue (ProF), Visual analogue scale, Hospital Anxiety and Depression Scale (HADS), OHIP-14 Scale, MDADI Scale and PSQI Scale were adopted to assess fatigue, depression, anxiety, xerostomia, xerophthalmia and sleep disturbances. Associations with fatigue were compared using multivariate regression. Results: 94% of our patients were women. The mean age of patients was 51.13±13.23 years, and the mean disease duration was 4.12±4.49 years. The mean oral dryness was 51±17.82, and the mean ocular dryness was 33.56±26.3. Abnormal fatigue, defined as an FSS score >or=4, was present in 64% of the patients. Dry symptoms, low educational level, Pain and depression had a negative impact on fatigue scores. The regression models explained that Pain and depression were the strongest predictors of fatigue according to the FSS. Conclusions: Fatigue is a tiredness which may be mental, physical, or both, and that results in an inability to function at normal performance levels. However, the underlying pathophysiological mechanisms of fatigue remain unclear. From our study, we found that psychosocial variables are determinants of fatigue, and fatigue is associated with depression, but depression is not the primary cause of fatigue in primary SS. Therefore, the investigation of the pathophysiologic correlates of physical and mental aspects of fatigue is needed to guide the development of more effective interventions.
